Aktiia Revolutionizes Blood Pressure Monitoring
March 9, 2024, 4:53 pm
Aktiia, a Swiss HealthTech company, secures USD 30M in funding to advance its mission of easing the global burden of hypertension through AI-driven technology. Led by Redalpine, the funding round includes investors like Khosla Ventures and Molten. Aktiia's wrist-worn optical blood pressure monitoring device offers personalized, continuous, and medical-grade data, empowering individuals and healthcare professionals. With the addition of Daniel Graf as President, Aktiia aims to pioneer advancements in hypertension management and provide predictive insights on a global scale. With over 1.4 billion people affected by high blood pressure worldwide, Aktiia is dedicated to making blood pressure management more accessible, accurate, and actionable for all.